Time is of the essence, so let’s get right to it.
I’ve just identified a handful of stocks that are primed to benefit from three exciting new trends in healthcare that I believe could potentially make you a large amount of money in the coming months.
In fact, if you’ll give me just a few minutes of your time, I’ll show you how you can instantly download this detailed list of healthcare stocks that I believe could make early investors as much as 300% profits over the next 12 to 24 months.
That’s right: Some of these stocks could very well double or even TRIPLE your money in a matter of months…
How do I know that?
Well, I know because 135 of these stocks have already at least doubled in value in the last 12 months.
More about that in a moment…
Your Market Sell-Off Protection Plan
Let me start by giving you a quick overview about why healthcare and biotech are so exciting right now — and why the right healthcare stocks can actually be the best protection you can have against a sudden market sell-off.
You see, healthcare is a cyclic industry that has seen many ups and downs.
But right now, we’re in the middle of a HUGE upswing in health stocks generally and in healthcare management in particular.
Ironically enough, this is occurring because of, not despite, concerns over the Affordable Care Act, also known as Obamacare.
And make no mistake: They are very few sectors that see the kind of life-changing profits as health.
In the past 12 months alone, you could have quickly DOUBLED your money… and in some cases TRIPLED your money… simply by investing in a handful of large-cap healthcare stocks.
For example, take a look at Celgene Corporation (CELG). Based in New Jersey, Celgene manufactures therapies for cancer and immune-inflammatory related diseases.
This is not a little company. It has annual sales of $5.7 billion.
But a year ago, Celgene stock was selling for around $67.49 a share. Today those same shares are going for $142.77 — a gain of 111.9%.
You would have more than doubled your money in a year.
And then there’s Gilead Sciences Inc (GILD), the $10 billion California drug company that developed one of the most popular HIV treatments, has seen its stock jump from $25.84 a share a year ago to $62.33 a share today.
That’s a gain of 141.25% in just 12 months.
I don’t have to tell you that profits like that can make a HUGE difference in your portfolio. They can provide an enormous cushion when the market as a whole takes a dive.
Take a look at a company with the unpronounceable name of Alnylam Pharmaceuticals (ALNY).
With $2.7 billion in sales, it makes various liver cancer drugs based on something called RNA interference (RNAi). Since the beginning of 2013, this company’s stock has skyrocketed from $18.83 a share to $45 a share right now.
That’s a gain of 140.26% in LESS than a year. Every $10,000 invested would have grown into $23,898 in a matter of months.
I have to say, it’s almost hard to find big healthcare companies that haven’t produced near triple-digit stock gains lately.
As I mentioned, at least 135 biotech and healthcare companies have seen their stock prices DOUBLE or almost double in value in the past 12 months.There’s…
… Boston Scientific (BSX)… up 119.3% in a year.
… Isis Pharmaceuticals (ISIS)… up 127.1% in the same period.
… Pharmacyclics (PCYC)… up 98.5%.
… Regeneron Pharmaceuticals (REGN)… up 97.4%.
… Pacira Pharmaceuticals (PCRX)… up 132.5%.
And here’s something else you should know: These are only the really BIG companies… the billion-dollar giants.
If we’re seeing 100% gains in a year with these big companies, you can just imagine the kinds of profits the mid-sized healthcare companies are seeing.
For example, look at Celldex Therapeutics. It’s a Massachusetts pharmaceutical company that is engineering a human monoclonal antibody for cancer. Its stock has risen from $5.21 a share a year ago to $20 today — a gain of 287.72% in a year.
The same thing happened with Clovis Oncology (CLVS), a brand new cancer drug manufacturer. Its stock leaped from $17.65 a share a year ago to $75 today. That’s a profit of 317.4%.
Another example is Puma Biotechnology (PBYI). It’s developing advanced therapies for advanced breast cancer patients and non-small cell lung cancer patients.
The company has seen its stock skyrocket from $12 a share a year ago to $53.72 today. That’s a 347.9% windfall… enough to turn a $10,000 flyer into $44,791.
Or look at ACADIA Pharmaceuticals (ACAD). In the past 12 months, Acadia’s stock has gone from $1.65 a share to… $18.67 a share.
That’s a profit of 1,031.52%.
That’s enough to turn every $10,000 into $100,000… and let me tell you, gains like that provide A LOT of protection for your portfolio.
I could go on and on… but you get the point.
Health care is RED HOT right now… one of the best performing sectors in the market.
And it shows no sign of slowing down.
Proof is in the Pudding.
I can honestly say that the top performing healthcare stocks can not only hand you triple-digit profits that are very difficult to find anywhere else, but they also tend to weather market downturns better than most other sector plays.
For example, take Gilead Sciences… one of the companies we just looked at.
Sure, it took a hit during the 2008-2009 stock crash… but over the past six and a half years, it’s posted an average annual compounded return of 23.7%.
Consistent profits like that provide a lot of protection for down years — and is enough to turn every $100,000 portfolio into $ 839,260 in just 10 years…
… and into $7 million in 20!
Of course, you’re not going to invest all your money in a single stock. That wouldn’t be prudent asset management.
But you can see how healthcare and biotech stocks can both boost your portfolio’s performance in the short-term while also providing a certain amount of protection over the long-term.
Now, let’s take a closer look at some of the game-changing trends that I see in the health sector right now—starting with a few of the hottest “mini-trends” and the companies I see benefiting the most from them.
One major healthcare trend I see is the development of new breakthrough treatments for once-ignored deadly diseases — diseases that are often called “orphan diseases.”
Orphan diseases are those that affect fewer than 200,000 people worldwide.
Examples include such potentially deadly ailments as Addison’s disease (which afflicted President John F. Kennedy), Crohn’s or Hodgkin disease…
… or common diseases such as tuberculosis, cholera and malaria that have been ignored because they is far more prevalent in developing countries than in the developed world.
In the past, the big pharmaceutical companies didn’t spend the time and resources to research and develop therapies for these types of diseases and many still have no known cure or treatment option.
And that’s why this is now a HUGE opportunity.
To develop treatments for these deadly ailments, the U.S. government and other countries around the world are now providing massive subsidies and enticements to increase profitability for the drug companies that do discover and provide therapies for “orphan” conditions.
And there’s ANOTHER reason as well: Big Pharma needs these treatments desperately!
According to EvaluatePharma Ltd., a London research firm, between now and 2016 blockbuster drugs with about $255 billion in global annual sales are set to go off patent.
That means huge losses for big pharmaceutical companies when their best-selling drugs patents start to expire.
For instance, when the patent for Pfizer’s Lipitor expired in November 2011, sales plummeted 71%.
It’s no surprise that as big pharmaceutical companies face shrinking pipelines and the influx of generic competition, they’re eager to acquire or partner with smaller biotech companies that have discovered potentially blockbuster new drugs… especially for highly targeted diseases such as tuberculosis and liver disease.
As The Wall Street Journal reports…
For example, right now I am recommending a tiny New York-based biotech pharmaceutical company that has discovered a new breakthrough drug to treat a rare autoimmune liver ailment.
What makes this remarkable “orphan disease” discovery even more exciting… and potentially more lucrative… is that the company’s future potential also lies in a number of intestinal and kidney diseases.
With no debt, over $114 million in cash on hand and an A-team of experienced doctors at the helm… this fast-growing NY-based biotech pharmaceutical is well financed for the future.
In addition… this well-managed emerging biotech powerhouse has a host of other groundbreaking liver, fibrosis and diabetes drugs in the pipeline that could not only further boost their earnings, but make them an even more desirable takeover target!
The company only went public last October… but already the stock has skyrocketed 136%.
That’s why I’m so excited to reveal to you this company’s name and full information in my timely report, New Healthcare Mega-Trends That Can Make You Rich.
It’s not too late to get in on this one, but you’ve got to act quickly!
Next up is another healthcare “mini-trend” pick can make early-bird investors a sizeable fortune in the next few months….
Healthcare Game-Changing Trend #2:
What I’m about to talk next is about as controversial as all get-out… but it could also make you an enormous amount of money.
After decades of false starts, health care information management… otherwise known as computerized medical records… is coming in a big way.
You can complain about it as much as you want.
You can protest and write your Congressman. You can even try to evade the system yourself in the name of maintaining your privacy.
But it’s coming… and it’s going to make some investors very, very rich.
The most recent driver is, of course, the Affordable Care Act — also known as Obamacare.
Healthcare spending is 17% of U.S. GDP, and as Baby Boomers age and need more healthcare services, knowing where every dollar goes and squeezing that dollar for efficient services will be of paramount importance to everyone who pays for it.
It’s no surprise, then, that spending on healthcare information technology (IT) is growing at a blistering 28% annual clip, according to industry research firm RNCOS.
Obamacare itself earmarked a staggering $60 billion (via grants and incentives) for the adoption of healthcare IT — and $20 billion of that sits squarely in the sweet spot of records automation.
Again, don’t get me wrong: I’m not saying computerized medical records are a good thing necessarily. There is a lot of potential for abuse and privacy concerns are certainly valid.
I’m just telling you that it’s coming — and you can get rich investing in the companies pioneering its development and implementation.
Simply put, the move to better and faster IT in the healthcare industry is a game changer.
It’s estimated that fully 35% of all physicians and hospitals still do not have electronic health record systems at all.
Only 50% to 60% of outpatient clinics have adopted software programs. This is a sizeable $6 billion market, so that leaves plenty of untapped customers.
Even more impressive is what the industry calls the “Revenue Cycle Management” market — bill collecting and management — which is a $50 billion market in terms of revenue potential.
I currently recommend a pioneer in this industry, a software-centric company in the medical information field that’s well positioned to ride a wave of healthcare IT spending.
The company’s software is currently used to track patient health records to make sure that professionals — within and outside points of care — are able to collect, receive and use data in real time.
To give you some idea just how BIG a trend computerized medical records is going to be, consider this:
Had you invested in the company I’m talking about 13 years ago, in 2000, you would have seen every $10,000 invested grow into…$313,479
That’s a total return of 3,037.5%.
On an annualized basis, that works out to be… 30.35% a year. At that rate, every $100,000 portfolio would grow into $1.3 million in just 10 years.
And here’s the exciting part of the story:
These staggering, life-changing profits all came…
… BEFORE Obamacare…
… BEFORE all the new government mandates…
… BEFORE the incentives and penalties that are driving computerized medical records.
If those profits happened just on industry demand alone, imagine what will happen going forward when the government insists — with fines and financial incentives — that every doctor’s office, clinic and hospital in America adopt these healthcare IT products?
I’ll tell you what will happen: Investors who get in now could potentially make a lot of money!
You’ll want to download your free copy of my detailed report, New Healthcare Mega-Trends That Can Make You Rich to get my specific buy advice on this stock.
Now, let’s discuss the last healthcare “mini-trend” that I know is going to change the healthcare industry, and make you rich along the way.
Game-Changing Healthcare Trend #3:
Here’s the situation in a nutshell.
The government is broke.
State governments are broke. City governments are broke. And the Federal government is especially broke. It’s spending $1.5 trillion a year it doesn’t have.
Yet the Federal government has promised to deliver health care services to all of its current and retired employees… to all returning soldiers and veterans… and, through Obamacare, to 35 million Americans without health insurance and to millions more with insurance.
Needless to say, it’s a problem… a very big problem.
What this is going to mean is that there is going to be HUGE pressure to reduce waste in healthcare spending and make sure that every dollar counts.
And as everyone knows, if there is one thing the government is NOT good at… it’s reducing wasteful spending!
As a result, the government is going to OUTSOURCE the delivery of health care services to private companies.
It has no choice.
It’s going to shift more and more Medicaid patients — including new patients enrolled as a result of Obamacare — from “fee for service” programs to “managed care.”
Again, I’m NOT saying this is a good thing. I’m just saying it’s coming.
A small group of companies is going to take over the management of Medicaid, Children’s Health Insurance Program (CHIP) and Medicare programs.
And early bird investors are going to cash in big time!
I am currently recommending one company that is smack dab in the center of this privatization effort.
It has a long track record (dating back to 1976) of providing its government customers quality healthcare services and delivering successful outcomes.
As a result, this company currently manages 17 state Medicaid managed care programs — that’s 52% of the total Medicaid managed care population.
It also administers the CHIP program in 19 states that account for 59% of the total CHIP population.
And this company is also in the middle of efforts to expand coverage.
For example, when Texas expanded its CHIP program in 2007, the company I’m talking about helped the state meet the challenges of increased enrollments, and collaborated with a state website to offer CHIP credit card payments online.
The company also started a special website that helps residents to apply for CHIP benefits and search for a plan or doctor.
Given the massive size of government spending on health care, you could say that business for this company has been good… really good. Quarterly revenues are up 34%… and earnings, year over year, are up a staggering 122%.
As for the stock, it’s been basically going straight up since 2008. It’s up 46% in the past 12 months…
And if you want to know just how profitable the healthcare sector is going to be going forward, consider this:
If you had purchased shares in this managed care company just four years ago, you would have already more than QUADRUPLED your money with a gain of 420.4%. It’s gained 46% just in the past 12 months!
That’s how you build serious wealth in a hurry!
A consistent return of 39% a year would let you turn a $100,000 portfolio into $ 518,888 in just 5 years and into $2,692,452 in 10 years.
That’s impressive… but I believe we’ll see even biggest gains over the next few months and years.
I explain all this in detail… and tell you all about my best current game-changing investments… in New Healthcare Mega-Trends That Can Make You Rich.
The Benefits of a Risk-Free GameChangers Membership
Every month, I give you my specially selected, low risk, high return game-changing picks.
At the moment, my GameChangers portfolio is stuffed with over 20 top stocks, carefully arranged into three categories:
And the best part is: I do ALL of the work for you!
All you have to do is simply follow my allocation strategy and assemble your portfolio using some of the lowest risk, biggest gainers in the market!
Try it out and see for yourself. When you agree to a risk-free TEST DRIVE, I’ll give you…
You get exact “Buy Below” prices for each and every stock on the GameChangers Buy List.
If a stock you want is below my buy price… then you can buy worry-free with minimized risk, at a price researched to maximize your return.
Now, you’re probably wondering how much a specialized advisory service like GameChangers might cost….
The answer is: Not as much as you might think!
Here’s A Steal of a Deal
It’s true that with our track record, we could sell GameChangers as a high-end trading service for professionals… and charge between $1,495 and $1,795 a year.
And that would be more than fair.
But to be honest, I want to reach A LOT more people than just professional money managers.
I made my first $1 million at age 30. I retired from the corridors of power on Wall Street at age 37.
My decision to help ordinary people — as opposed to Wall Street money managers — was a very deliberate one.
As a result, we decided on a regular subscription price for GameChangers service of only $199…
When you consider the track record behind GameChangers… and the astonishing profits we’ve made even just so far in 2013… that’s a pretty good and fair offer.
But frankly, I don’t want any barriers to you giving GameChangers a try—especially now that healthcare and biotech stocks are on a tear.
So, I’ve arranged for you to receive a full 50% off of our regular price —and pay just $99 for a full a year of my monthly GameChanger picks and weekly guidance.
This offer will NOT last long. It’s a limited-time offer designed, quite frankly, to get you to take action immediately.
This is a steal of a deal — especially when you factor in our outstanding track record!
So far in 2013, you could have easily made up to 50 times the cost of a trial subscription on a single GameChangers recommendation.
That’s NOT an exaggeration.
A $10,000 flyer on Exact Target would have netted you an extra $5,637.
And that’s just one of my recent winners!
But there’s one problem: This special “Healthcare Mega-Trends” membership offer won’t last long.
I can’t say how long my publishers will let me keep the price so absurdly low… So, here’s what I propose you do:
You can take as much time as you need to check out my unique approach to building real wealth by investing in “game changer” companies like Apple… or like the healthcare stocks I’ve mentioned in this video.
You’ll also get TWO additional bonus reports that will help you make even MORE money in the months and weeks ahead. They are…
One of the most powerful game-changing trends right now is the increasing integration of technology and communication in all areas of our lives. This is happening at a personal level in our homes and with the mobile devices that keep us connected anytime and anywhere.
In this remarkable report, I tell you about 3 companies that I believe will completely dominate the new mobile computing, smart-phone universe — and reveal how you can make a small fortune by investing in the industry leaders right now.
From the credit card you swipe at Walmart, to the ID number you use to clock in at work, to the pictures you upload on Facebook, data has become a significant part of who we are and what we do every day. Each piece of information we create is a tiny slice of a very big pie.
In total, Walmart handles more than one million customer transactions every hour, which is imported into databases estimated to contain more than 2.5 petabytes of data—the equivalent of 167 times the information contained in all the books in the U.S. Library of Congress. In this privately printed report, you’ll discover three stocks I believe are going to take over entire segments of the Big Data world — such the world’s largest data storage provider with about a 20% share of the market.
This one report alone is worth the entire cost of your trial subscription.
But with this special limited-time offer, you can get all of the special reports mentioned today without spending a single penny…
I recommend you study the stock picks in these reports carefully… do your own due diligence… and then invest in a couple of them as a test. (If you want, you can also paper-trade them and just follow them informally.)
I’m pretty confident that you’ll be astonished at the results.
As I mentioned earlier, we’ve closed out 15 double-digit winners so far in 2013 that you owe it to yourself to see these types of returns in your own portfolio.
Plus, as I said, you can take up to SIX full months to see how these investments work out.
If you’re not piling up profits far faster than you have in the past… or if you’re dissatisfied for any reason… just call the customer service number you find on our website and in every issue.
We’ll refund every cent you paid for your trial subscription — and you get to keep everything you’ve received up to that point (including any profits!) as our thank you for giving us a try.
That’s why I strongly urge you to take advantage of our zero-risk test drive … and our special low offer of just $99 a year.
You have literally nothing to lose… and a lot of profits to gain.
The Profit Potential is HUGE
Let me remind you of just HOW big these profits are:
Please, don’t hesitate. You can always cancel and get a full refund if you don’t make the profits I say you can make.
Take advantage of our limited-time offer — and put the power of game-changing investments to work for your portfolio… and your future prosperity.